A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma (Q33330428)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma |
scientific article |
Statements
1 reference
A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma (English)
1 reference
Mahé MA
1 reference
Fumoleau P
1 reference
Fabbro M
1 reference
Guastalla JP
1 reference
Faurous P
1 reference
Chauvot P
1 reference
Chetanoud L
1 reference
Classe JM
1 reference
Rouanet P
1 reference
Chatal JF
1 reference
1 October 1999
1 reference
1 reference